"Family business, 100% holding, is this the inheritance of 'medicine' from generation to generation in the new era?" The "Shulan turmoil" set off in the medical industry makes people dumbfounded. When the "anti-epidemic hero" Academician Li Lanjuan and her family's 100% controlled "Shulan Medical" surfaced, the public's attention instantly focused. Is it the continuation of honor, or the entanglement of interests? Today, let us unveil this veil of mystery together.
Imagine, on the battlefield of fighting the epidemic, Academician Li Lanjuan is like a brave general, leading the team to charge into battle and winning countless praises. However, when the smoke of the battlefield cleared, the general turned around and threw himself into the torrent of commerce, and co-helmed a ship called "Shulan Medical" with his family. The ship, which is a family business owned by the Li family, is 100% controlled by the Li family, and Li Lanjuan's two sons hold 60% and 40% of the shares respectively.
This is a family story, but it caused an uproar because of a financial report. According to the report, Shulan Medical's debt ratio is as high as an astonishing 100%. People began to question what kind of secrets this medical company endorsed as an "anti-epidemic hero" was hidden.
Some netizens ridiculed: "Could it be that this is a 'doctor' crown who is making money while saving people?" Indeed, when healthcare and business are closely linked, when the label of "anti-epidemic hero" is combined with a 100% owned family business, it is difficult for people not to associate with it.
Academician Li Lanjuan's contribution during the fight against the epidemic is indelible. But when her name is associated with a debt-ridden, family-owned medical company, all sorts of associations are inevitable. Does this mean that some "anti-epidemic heroes" also have an unknown side behind their halos, and are they just using their fame and influence to seek more business benefits for their families?
We have to admit that the operation of medical enterprises is inseparable from business logic. Creating medical needs and creating profits is the only way for the development of enterprises. However, Shulan Medical's data seems to favor profits and valuations too much, which makes one wonder: while pursuing commercial success, do you ignore the essence of medical enterprises - saving lives and fulfilling social responsibilities?
Perhaps, we can interpret this phenomenon from another angle. As a leader in the medical field, Academician Li Lanjuan and her family undoubtedly have abundant medical resources and profound professional knowledge. They may have started Shulan Medical to translate these resources and knowledge into broader social services. However, the harsh realities of the business world have forced them to face various challenges, including financial pressures and market competition. In this case, the pursuit of profit may be an inevitable choice for them to maintain business operations and achieve long-term development.
However, in any case, the high debt ratio of "Shulan Medical" is a problem that cannot be ignored. Does this mean that the company is too aggressive in the process of expansion and neglects risk control? Or is there a deeper hidden story behind it? These are questions that only the Li family can answer.
In this "Shulan Turmoil", we have seen the collision of business and morality, and also the interweaving of interests and responsibilities. We can't help but ask: In the business world, can we find a balance that can not only realize commercial value, but also adhere to the moral bottom line? This is undoubtedly a severe test for the "anti-epidemic hero" Academician Li Lanjuan and her family business.
Finally, we would like to say that no matter what the future of "Shulan Medical" is, we hope that Academician Li Lanjuan and her family can stick to the original intention of doctors and never forget their social responsibilities. Because, in them, we place too much expectation and trust. We hope that they can use their expertise and resources to bring health and hope to more people.
At the end of this story, we can't help but ask: What do you think of the phenomenon of "Shulan Medical"? How do you think family-controlled medical companies should balance commercial interests and social responsibility? Perhaps, everyone has an answer in their hearts. But in any case, we all look forward to "Shulan Medical" to find its own path and become a clear stream in the medical industry.